Summary
143.80 0.99(0.69%)07/08/2025
DaVita Inc. (DVA)
DVA reported last earnings on 2025-05-12 after the market. An EPS of $2 was observed compared to an estimated EPS of $1.95, resulting in a surprise value of $0.05. A revenue of $3,224 million was observed compared to an estimated revenue of $3,207 million, resulting in a surprise value of $17 Million.
DaVita Inc. (DVA)
Key Facts
| 1 Day | 1 Week | 1 Month | 3 Months | 6 Months | 1 Year | 5 Years |
| 0.69 | -1.98 | 0.00 | -0.08 | -6.60 | 4.67 | 80.34 |
Last 730 data points are shown. To view all data, Upgrade to PRO plan!
Fundamental Ratings
| Category | Rating |
| Main Rating | B- |
| Recommended Rating | Neutral |
| DCF | Strong Buy |
| ROE | Strong Sell |
| ROA | Buy |
| Debt/Equity | Strong Sell |
| P/E | Neutral |
| P/B | Strong Sell |
Earnings
| Trading Data | ||
| Close | 143.80 | |
| Open | 142.20 | |
| High | 145.88 | |
| Low | 141.89 | |
| Volume | 826,675 | |
| Change | 0.99 | |
| Change % | 0.69 | |
| Avg Volume (20 Days) | 857,728 | |
| Volume/Avg Volume (20 Days) Ratio | 0.96 | |
| 52 Week Range | 134.00 - 179.60 | |
| Price vs 52 Week High | -19.93% | |
| Price vs 52 Week Low | 7.31% | |
| Range | 0.00 | |
| Gap Up/Down | -1.69 | |
Profitibility | ||
| Market Capitalization (Mln) | 10,512 | |
| Revenue per share | 163.3974 | |
| Net Income per share | 10.8307 | |
| Dividend Yield | 0.0000 | |
| Dividend Share | 0.00% | |
Valuations | ||
| Enterprise Value | 0.00% | |
| PE Ratio | 13.2771 | |
| PB Ratio | 0.0000 | |
| PTB Ratio | 0.0000 | |
Liquidity | ||
| Debt/Equity Ratio | 0.0000 | |
| Net Debt/EBIDTA Ratio | 0.0000 | |
| Current Ratio | 0.0000 | |
Enterprise Value and Cash Flow | ||
| EV/Sales Ratio | 0.0000 | |
| EV/EBIDTA Ratio | 0.0000 | |
| EV/Free Cash Flow Ratio | 0.0000 | |
07/02 11:10 EST - zacks.com
4 Stocks to Watch in a Rapidly Shifting Outpatient Home Health Space
An aging global population and AI dominance are likely to drive the Zacks Medical - Outpatient and Home Healthcare industry despite the macroeconomic challenges. DGX, EHC, DVA and PNTG are well-poised to gain.
4 Stocks to Watch in a Rapidly Shifting Outpatient Home Health Space
An aging global population and AI dominance are likely to drive the Zacks Medical - Outpatient and Home Healthcare industry despite the macroeconomic challenges. DGX, EHC, DVA and PNTG are well-poised to gain.
07/02 10:46 EST - zacks.com
Why DaVita HealthCare (DVA) is a Top Value Stock for the Long-Term
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Why DaVita HealthCare (DVA) is a Top Value Stock for the Long-Term
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
07/01 19:16 EST - zacks.com
DaVita HealthCare (DVA) Rises As Market Takes a Dip: Key Facts
In the closing of the recent trading day, DaVita HealthCare (DVA) stood at $146.71, denoting a +2.99% move from the preceding trading day.
DaVita HealthCare (DVA) Rises As Market Takes a Dip: Key Facts
In the closing of the recent trading day, DaVita HealthCare (DVA) stood at $146.71, denoting a +2.99% move from the preceding trading day.
06/16 19:01 EST - zacks.com
DaVita HealthCare (DVA) Outperforms Broader Market: What You Need to Know
DaVita HealthCare (DVA) reached $137.84 at the closing of the latest trading day, reflecting a +1.26% change compared to its last close.
DaVita HealthCare (DVA) Outperforms Broader Market: What You Need to Know
DaVita HealthCare (DVA) reached $137.84 at the closing of the latest trading day, reflecting a +1.26% change compared to its last close.
05/30 14:35 EST - prnewswire.com
DaVita Statement on Government's Kidney Care Choices (KCC) Model Updates
DENVER , May 30, 2025 /PRNewswire/ -- DaVita, a comprehensive kidney care company, issued the following statement in response to updates this week from the Center for Medicare and Medicaid Innovation (CMMI) related to its Kidney Care Choices (KCC) Model. It can be attributed to Misha Palecek,...
DaVita Statement on Government's Kidney Care Choices (KCC) Model Updates
DENVER , May 30, 2025 /PRNewswire/ -- DaVita, a comprehensive kidney care company, issued the following statement in response to updates this week from the Center for Medicare and Medicaid Innovation (CMMI) related to its Kidney Care Choices (KCC) Model. It can be attributed to Misha Palecek,...
05/30 10:40 EST - zacks.com
Here's Why DaVita HealthCare (DVA) is a Strong Value Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Here's Why DaVita HealthCare (DVA) is a Strong Value Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
05/27 11:30 EST - seekingalpha.com
DaVita: International Expansion And Buybacks Will Boost Returns
International expansion continues with new clinics in Brazil, Ecuador, Chile, and Colombia, supporting long-term growth beyond the US market. DaVita's stock offers a 10% FCF yield, and the share count is decreasing at a fast pace. On top of share buybacks, the company will grow revenues above...
DaVita: International Expansion And Buybacks Will Boost Returns
International expansion continues with new clinics in Brazil, Ecuador, Chile, and Colombia, supporting long-term growth beyond the US market. DaVita's stock offers a 10% FCF yield, and the share count is decreasing at a fast pace. On top of share buybacks, the company will grow revenues above...
05/20 16:42 EST - prnewswire.com
DaVita Inc. Announces Upsize and Pricing of $1 Billion Senior Notes Offering
DENVER , May 20, 2025 /PRNewswire/ -- DaVita Inc. (NYSE: DVA) ("DaVita") announced today the upsize and pricing of its previously announced private offering (the "offering") of its 6.750% senior notes due 2033 (the "2033 notes"). The aggregate principal amount of the 2033 notes offered in the...
DaVita Inc. Announces Upsize and Pricing of $1 Billion Senior Notes Offering
DENVER , May 20, 2025 /PRNewswire/ -- DaVita Inc. (NYSE: DVA) ("DaVita") announced today the upsize and pricing of its previously announced private offering (the "offering") of its 6.750% senior notes due 2033 (the "2033 notes"). The aggregate principal amount of the 2033 notes offered in the...
05/20 09:05 EST - prnewswire.com
DaVita Releases Annual Community Care Report, Highlights Achievements in Corporate Citizenship
Captures key initiatives achieved in 2024, driving 2025 ESG goals DENVER , May 20, 2025 /PRNewswire/ -- Today, DaVita (NYSE: DVA) published its Community Care report, underpinning its long-standing commitment to corporate citizenship and highlighting strides made towards ambitious Environmental,...
DaVita Releases Annual Community Care Report, Highlights Achievements in Corporate Citizenship
Captures key initiatives achieved in 2024, driving 2025 ESG goals DENVER , May 20, 2025 /PRNewswire/ -- Today, DaVita (NYSE: DVA) published its Community Care report, underpinning its long-standing commitment to corporate citizenship and highlighting strides made towards ambitious Environmental,...
05/20 08:51 EST - prnewswire.com
DaVita Inc. Announces Offering of $750 Million Senior Notes
DENVER , May 20, 2025 /PRNewswire/ -- DaVita Inc. (NYSE: DVA) ("DaVita")Â announced today that it has commenced a private offering (the "offering") of $750 million aggregate principal amount of its senior notes due 2033 (the "2033 notes"), subject to market and other conditions. DaVita intends to...
DaVita Inc. Announces Offering of $750 Million Senior Notes
DENVER , May 20, 2025 /PRNewswire/ -- DaVita Inc. (NYSE: DVA) ("DaVita")Â announced today that it has commenced a private offering (the "offering") of $750 million aggregate principal amount of its senior notes due 2033 (the "2033 notes"), subject to market and other conditions. DaVita intends to...
05/15 10:50 EST - zacks.com
Here's Why DaVita HealthCare (DVA) is a Strong Growth Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Here's Why DaVita HealthCare (DVA) is a Strong Growth Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
05/13 13:15 EST - zacks.com
DaVita Stock Down Despite Q1 Earnings Beat, Margins Contract
Strength in revenue per treatment and dialysis patient service revenues drives DVA's first-quarter 2025 performance despite a year-over-year decline in normalized non-acquired treatment.
DaVita Stock Down Despite Q1 Earnings Beat, Margins Contract
Strength in revenue per treatment and dialysis patient service revenues drives DVA's first-quarter 2025 performance despite a year-over-year decline in normalized non-acquired treatment.
05/12 21:41 EST - seekingalpha.com
DaVita Inc. (DVA) Q1 2025 Earnings Call Transcript
DaVita Inc. (NYSE:DVA ) Q1 2025 Earnings Conference Call May 12, 2025 5:00 PM ET Company Participants Nic Eliason - Group VP, IR Javier Rodriguez - CEO Joel Ackerman - CFO Conference Call Participants Andrew Mok - Barclays Christian Porter - Bank of America Dean Rosales - Wolfe Research Pito...
DaVita Inc. (DVA) Q1 2025 Earnings Call Transcript
DaVita Inc. (NYSE:DVA ) Q1 2025 Earnings Conference Call May 12, 2025 5:00 PM ET Company Participants Nic Eliason - Group VP, IR Javier Rodriguez - CEO Joel Ackerman - CFO Conference Call Participants Andrew Mok - Barclays Christian Porter - Bank of America Dean Rosales - Wolfe Research Pito...
05/12 18:20 EST - zacks.com
DaVita HealthCare (DVA) Q1 Earnings and Revenues Beat Estimates
DaVita HealthCare (DVA) came out with quarterly earnings of $2 per share, beating the Zacks Consensus Estimate of $1.75 per share. This compares to earnings of $2.38 per share a year ago.
DaVita HealthCare (DVA) Q1 Earnings and Revenues Beat Estimates
DaVita HealthCare (DVA) came out with quarterly earnings of $2 per share, beating the Zacks Consensus Estimate of $1.75 per share. This compares to earnings of $2.38 per share a year ago.
05/12 16:51 EST - investopedia.com
DaVita First-Quarter 2025 Financial Results: Just the Numbers
Kidney treatment company DaVita (DVA) on Monday afternoon reported first-quarter 2025 financial results. A summary of its key numbers is below.
DaVita First-Quarter 2025 Financial Results: Just the Numbers
Kidney treatment company DaVita (DVA) on Monday afternoon reported first-quarter 2025 financial results. A summary of its key numbers is below.
05/12 16:05 EST - prnewswire.com
DaVita Inc. 1st Quarter 2025 Results
DENVER , May 12, 2025 /PRNewswire/ -- DaVita Inc. (NYSE: DVA) announced financial and operating results for the quarter ended March 31, 2025. "Our strong first quarter performance demonstrates the stability and consistency of our operating model" said Javier Rodriguez, CEO of DaVita Inc. "We...
DaVita Inc. 1st Quarter 2025 Results
DENVER , May 12, 2025 /PRNewswire/ -- DaVita Inc. (NYSE: DVA) announced financial and operating results for the quarter ended March 31, 2025. "Our strong first quarter performance demonstrates the stability and consistency of our operating model" said Javier Rodriguez, CEO of DaVita Inc. "We...
05/08 12:55 EST - zacks.com
Can Revenue Cycle Operations Drive DVA Stock Before Q1 Earnings?
Continued strength in revenue cycle operations is likely to have boosted DaVita's top line in the first quarter despite supply challenges weighing on its performance.
Can Revenue Cycle Operations Drive DVA Stock Before Q1 Earnings?
Continued strength in revenue cycle operations is likely to have boosted DaVita's top line in the first quarter despite supply challenges weighing on its performance.